BioSpecifics Technologies Corp. (BSTC) |
|
66.35 4.04 (6.48%)
|
07-07 15:59 |
|
Open: |
65 |
Pre. Close: |
62.31 |
|
High:
|
69.5138 |
Low:
|
65 |
|
Volume:
|
84,295 |
Market Cap:
|
487M |
|
|
|
|
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
65.067 - 65.422 |
65.422 - 65.717 |
|
Low:
|
60.287 - 60.715 |
60.715 - 61.071 |
|
Close:
|
61.656 - 62.318 |
62.318 - 62.869 |
|
Technical analysis |
as of: 2020-07-07 3:32:33 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 81.19  One year: 94.83 |
| Support: |
Support1: 62.34 Support2: 57.91 |
| Resistance: |
Resistance1: 69.51 Resistance2: 81.19 |
| Pivot: |
61.55 |
| Moving Average: |
MA(5): 63.03 MA(20): 61.58
MA(100): 57.37 MA(250): 56.49 |
| MACD: |
MACD(12,26): Signal(9): 0.75 |
| Stochastic oscillator: |
%K(14,3): 64.94  %D(3): 64.90 |
| RSI: |
RSI(14): 62.40 |
| 52-week: |
High: 69.51 Low: 42.00 Change(%): 4.6 |
| Average Vol(K): |
3-Month: 3841 10-Days: 4422 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BSTC has closed above the upper band by 11.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 30.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 07 Jul 2020
Timing the Market, Is it Possible? - July 07, 2020 - Yahoo Finance
Tue, 07 Jul 2020
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold - Yahoo Finance
Mon, 06 Jul 2020
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus - Benzinga
Wed, 01 Jul 2020
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates - Benzinga
Fri, 26 Jun 2020
Hedge Funds Souring On BioSpecifics Technologies Corp. (BSTC) - Yahoo Finance
Mon, 22 Jun 2020
BioSpecifics Technologies Corp (BSTC) Soars 2.03% on June 22 - Equities.com
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
7 |
| Shares Float (M) |
5 |
|
% Held by Insiders
|
26.15 |
|
% Held by Institutions
|
66.74 |
|
Shares Short (K)
|
278 |
|
Shares Short P. Month (K)
|
293 |
Stock Financials |
|
EPS
|
3.340 |
|
EPS Est This Year
|
1.590 |
|
EPS Est Next Year
|
1.690 |
|
Book Value (p.s.)
|
17.620 |
|
Profit Margin
|
61.80 |
|
Operating Margin
|
74.55 |
|
Return on Assets (ttm)
|
15.5 |
|
Return on Equity (ttm)
|
21.2 |
|
Qtrly Rev. Growth
|
18.9 |
|
Gross Profit (p.s.)
|
5.203 |
|
Sales Per Share
|
5.413 |
|
EBITDA (p.s.)
|
4.053 |
|
Qtrly Earnings Growth
|
1.90 |
|
Operating Cash Flow (M)
|
24 |
|
Levered Free Cash Flow (M)
|
18 |
Stock Valuations |
|
PE Ratio
|
19.71 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.74 |
|
Price to Sales
|
12.16 |
|
Price to Cash Flow
|
19.75 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
